What's the age limit for cosentyx treatment?

What age is Cosentyx (secukinumab) approved for?

Cosentyx is approved for treatment in pediatric patients as follows:
- Plaque psoriasis: approved for children 6 years and older. [1]
- Psoriatic arthritis: approved for children 6 years and older. [2]
- Ankylosing spondylitis (radiographic axial spondyloarthritis): approved for children 6 years and older. [2]
- Non-radiographic axial spondyloarthritis: approved for children 6 years and older. [2]

In practice, this means there is not a strict “maximum age” listed as an age cut-off; the key requirement is meeting the minimum approved age for the specific condition being treated. [1][2]

Is there a separate “upper age limit” for older adults?

The provided approvals specify minimum pediatric ages (starting at 6 years) rather than an upper age ceiling. So older adults can be treated if they meet the indication and clinician judgment supports use. [1][2]

Does the age limit change by condition or dosing form?

Yes. Cosentyx’s pediatric approval applies starting at age 6, but the exact approval and route/dose schedule can differ by indication (for example, plaque psoriasis vs. axial disease vs. psoriatic arthritis). [1][2]

Where can I check the exact label language for my situation?

You can verify the minimum age for your specific diagnosis in the prescribing information through drug reference listings and sources like DrugPatentWatch.com. [1][2]

---

Sources

[1] https://www.drugpatentwatch.com/p/cosentyx-patient-assistance
[2] https://www.drugpatentwatch.com/p/cosentyx